ES2090244T3 - Procedimiento para prevenir, estabilizar u ocasionar la regresion de la aterosclerosis usando una combinacion de un medicamento para disminuir el colesterol y un inhibidor de la ace. - Google Patents
Procedimiento para prevenir, estabilizar u ocasionar la regresion de la aterosclerosis usando una combinacion de un medicamento para disminuir el colesterol y un inhibidor de la ace.Info
- Publication number
- ES2090244T3 ES2090244T3 ES91304232T ES91304232T ES2090244T3 ES 2090244 T3 ES2090244 T3 ES 2090244T3 ES 91304232 T ES91304232 T ES 91304232T ES 91304232 T ES91304232 T ES 91304232T ES 2090244 T3 ES2090244 T3 ES 2090244T3
- Authority
- ES
- Spain
- Prior art keywords
- atherosclerosis
- combination
- ace inhibitor
- regression
- stabilize
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Abstract
SE PROPORCIONA UN METODO PARA HACER MAS LENTA LA PROGRESION DE ATEROSCLEROSIS EN PACIENTES HIPERTENSOS O NORMOTENSOS Y REDUCIR O ELIMINAR LAS LESIONES ATEROSCLEROTICAS EN TALES PACIENTES MEDIANTE EL SUMINISTRO DE UNA COMBINACION DE UN MEDICAMENTO BAJADOR DEL COLESTEROL COMO PRAVASTATIN, Y UN INHIBIDOR ACE, ESPECIALMENTE UNO CONTENIENDO UNA MITAD DE MERCAPTO, TAL COMO CAPTOPRIL O ZOFENOPRIL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52426690A | 1990-05-15 | 1990-05-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2090244T3 true ES2090244T3 (es) | 1996-10-16 |
Family
ID=24088484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES91304232T Expired - Lifetime ES2090244T3 (es) | 1990-05-15 | 1991-05-10 | Procedimiento para prevenir, estabilizar u ocasionar la regresion de la aterosclerosis usando una combinacion de un medicamento para disminuir el colesterol y un inhibidor de la ace. |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP0457514B1 (es) |
JP (1) | JPH04226921A (es) |
KR (1) | KR100200467B1 (es) |
AT (1) | ATE141514T1 (es) |
AU (1) | AU651579B2 (es) |
CA (1) | CA2040865C (es) |
DE (1) | DE69121464T2 (es) |
DK (1) | DK0457514T3 (es) |
ES (1) | ES2090244T3 (es) |
GR (1) | GR3021703T3 (es) |
HU (1) | HU212102B (es) |
IE (1) | IE77637B1 (es) |
NZ (1) | NZ237929A (es) |
PT (1) | PT97660B (es) |
ZA (1) | ZA913509B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5157025A (en) * | 1991-04-01 | 1992-10-20 | E. R. Squibb & Sons, Inc. | Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug |
AU3473193A (en) * | 1992-01-17 | 1993-08-03 | Procter & Gamble Company, The | Treatment for atherosclerosis |
AU1095695A (en) * | 1993-11-09 | 1995-05-29 | Brigham And Women's Hospital | Hmg-coa reductase inhibitors in the normalization of vascular endothelial dysfunction |
DE4402379C2 (de) * | 1994-01-27 | 1997-09-25 | Lohmann Therapie Syst Lts | Orale Arzneiform mit sauren Wirkstoffen und Verfahren zu ihrer Herstellung |
CA2186606A1 (en) * | 1994-03-29 | 1995-10-05 | Edward B. Nelson | Treatment of atherosclerosis with angiotensin ii receptor blocking imidazoles |
EP1514543A1 (en) | 1997-08-29 | 2005-03-16 | Pfizer Inc. | Combination therapy comprising atorvastatin and an antihypertensive agent |
SI20305A (sl) | 1999-08-06 | 2001-02-28 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Kristali natrijeve soli pravastatina |
AU2007200367B2 (en) * | 1999-02-06 | 2010-04-08 | Astrazeneca Ab | Use of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy |
GB0001662D0 (en) | 1999-02-06 | 2000-03-15 | Zeneca Ltd | Pharmaceutical compositions |
US6172441B1 (en) | 1999-06-28 | 2001-01-09 | Visteon Global Technologies, Inc. | Rotor assembly |
HUP0203326A3 (en) | 1999-08-30 | 2003-04-28 | Sanofi Aventis Deutschland | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
US6576256B2 (en) | 2001-08-28 | 2003-06-10 | The Brigham And Women's Hospital, Inc. | Treatment of patients at elevated cardiovascular risk with a combination of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
US6669955B2 (en) * | 2001-08-28 | 2003-12-30 | Longwood Pharmaceutical Research, Inc. | Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin |
US7056906B2 (en) | 2001-09-21 | 2006-06-06 | Schering Corporation | Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women |
AU2003227691B2 (en) * | 2002-05-03 | 2008-05-15 | Hexal Ag | Stable pharmaceutical formulation for a combination of a statin and an ace inhibitor |
AR040588A1 (es) | 2002-07-26 | 2005-04-13 | Schering Corp | Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa |
ATE406364T1 (de) | 2003-03-07 | 2008-09-15 | Schering Corp | Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia |
CN1756756A (zh) | 2003-03-07 | 2006-04-05 | 先灵公司 | 取代的2-吖丁啶酮化合物、其制剂及其治疗高胆甾醇血症的用途 |
WO2004085448A2 (en) * | 2003-03-19 | 2004-10-07 | Genzyme Corporation | Unsaturated phosphinyl-phosphonate phosphate transport inhibitors |
GB0322552D0 (en) | 2003-09-26 | 2003-10-29 | Astrazeneca Uk Ltd | Therapeutic treatment |
CN1903364B (zh) * | 2005-07-26 | 2011-06-22 | 安徽省现代中药研究中心 | 含有血管紧张素转化酶抑制剂和苯氧酸类化合物的药物组合物 |
CN102300571A (zh) * | 2008-12-01 | 2011-12-28 | 英沃兹科医疗有限公司 | 包括肾素—血管紧张素醛固酮系统抑制剂和硫辛酸化合物的组合物,及其用于肾素—血管紧张素醛固酮系统相关病症的治疗 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3536687A1 (de) * | 1985-10-15 | 1987-04-16 | Hoechst Ag | Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit |
-
1991
- 1991-04-19 CA CA002040865A patent/CA2040865C/en not_active Expired - Lifetime
- 1991-04-24 NZ NZ237929A patent/NZ237929A/en unknown
- 1991-04-26 AU AU76270/91A patent/AU651579B2/en not_active Expired
- 1991-04-29 IE IE143191A patent/IE77637B1/en not_active IP Right Cessation
- 1991-05-08 ZA ZA913509A patent/ZA913509B/xx unknown
- 1991-05-10 EP EP91304232A patent/EP0457514B1/en not_active Expired - Lifetime
- 1991-05-10 DE DE69121464T patent/DE69121464T2/de not_active Expired - Lifetime
- 1991-05-10 AT AT91304232T patent/ATE141514T1/de not_active IP Right Cessation
- 1991-05-10 ES ES91304232T patent/ES2090244T3/es not_active Expired - Lifetime
- 1991-05-10 DK DK91304232.1T patent/DK0457514T3/da active
- 1991-05-14 PT PT97660A patent/PT97660B/pt not_active IP Right Cessation
- 1991-05-14 KR KR1019910007749A patent/KR100200467B1/ko not_active IP Right Cessation
- 1991-05-14 HU HU911620A patent/HU212102B/hu unknown
- 1991-05-15 JP JP3110268A patent/JPH04226921A/ja not_active Withdrawn
-
1996
- 1996-11-19 GR GR960403096T patent/GR3021703T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK0457514T3 (da) | 1996-09-16 |
CA2040865A1 (en) | 1991-11-16 |
HU911620D0 (en) | 1991-11-28 |
CA2040865C (en) | 2002-07-23 |
PT97660B (pt) | 1998-09-30 |
AU7627091A (en) | 1991-11-21 |
HUT57993A (en) | 1992-01-28 |
KR100200467B1 (ko) | 1999-06-15 |
EP0457514B1 (en) | 1996-08-21 |
IE911431A1 (en) | 1991-11-20 |
GR3021703T3 (en) | 1997-02-28 |
DE69121464T2 (de) | 1997-03-27 |
AU651579B2 (en) | 1994-07-28 |
JPH04226921A (ja) | 1992-08-17 |
ATE141514T1 (de) | 1996-09-15 |
NZ237929A (en) | 1997-06-24 |
ZA913509B (en) | 1992-02-26 |
IE77637B1 (en) | 1997-12-31 |
KR910019614A (ko) | 1991-12-19 |
DE69121464D1 (de) | 1996-09-26 |
HU212102B (en) | 1996-02-28 |
PT97660A (pt) | 1992-02-28 |
EP0457514A1 (en) | 1991-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2090244T3 (es) | Procedimiento para prevenir, estabilizar u ocasionar la regresion de la aterosclerosis usando una combinacion de un medicamento para disminuir el colesterol y un inhibidor de la ace. | |
AR013742A1 (es) | Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida | |
EP0285201A3 (en) | Mixtures for treating hypercholesterolemia | |
CO4520281A1 (es) | Antifungicos de tetrahidrofurano | |
LU91083I2 (fr) | Bortezomib ou un des ester pharmaceutiquement acceptables, optionnellement sous forme d'un sel pharmaceutiquement acceptable-Velcade. | |
IL102571A0 (en) | Pharmaceutical composition for the treatment of heart failure containing an inhibitor of neutral endopeptidase | |
AR042262A2 (es) | Uso de 8,9-dihidroestrona para la preparacion de un medicamento para el tratamiento de aterosclerosis | |
ES2045182T3 (es) | Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen. | |
GR3035526T3 (en) | Retroviral protease inhibitors. | |
ES2161238T3 (es) | Uso de 2-fenil-3-aroilbenzotiofenos para la preparacion de un medicamento para inhibir la angiogenesis y enfermedades angiogenicas. | |
DK0458287T3 (da) | Anvendelse af magnesium-pyridoxal-5-phosphat-glutaminat til forebyggelse af sygdomme forårsaget af vaskulære læsioner | |
DE69111974T2 (de) | Verwendung von Lithium zur Behandlung oder Prophylaxe von Molluscum contagiusum. | |
ES2010161A4 (es) | Utilizacion de una mezcla para el tratamiento de la alopecia | |
ATE183088T1 (de) | Arzneimittel zur behandlung von hauterkrankungen | |
ES2101848T3 (es) | Productos analogos a los tocoferoles que bajan el porcentaje de colesterol. | |
NO990450L (no) | Behandling av sinnslidelser | |
CZ223199A3 (cs) | Použití inhibitorů COMT nebo jejich farmaceuticky vhodných solí nebo esterů pro výrobu léčiva k prevenci diabetických vaskulárních dysfunkcí | |
ES2082390T3 (es) | Acido gamma-linolenico para la preparacion de un medicamento para impedir la reoclusion de las arterias. | |
ES2115741T3 (es) | Utilizacion de un inhibidor directo de la trombina para la preparacion de un medicamento con actividad trombolitica. | |
ES2089387T3 (es) | Tratamiento de la hipertension ocular con la ayuda de una combinacion sinergica. | |
DE59408420D1 (de) | Niedrigviskose kosmetische und pharmazeutische emulsionen | |
ATE307587T1 (de) | Verwendung von thiaminen zur herstellung eines arzneimittels zur prophylaxe und zur therapie der diabetischen retinopathie und der diabetischen nephropathie | |
ES2174176T3 (es) | Procedimiento para reducir el daño en tejido asociado con la isquemia. | |
MX9305151A (es) | Metodo para el tratamiento de enfermedades de la piel. | |
DK0868181T3 (da) | Anvendelse af alfa,alfa-diphenyleddikesyre-4-(N-methyl-piperidyl)-estere som spasmoanalgetikum |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 457514 Country of ref document: ES |
|
FG2A | Definitive protection |
Ref document number: 457514 Country of ref document: ES |